F13714 fumarate
new
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 556068

CAS#: 208109-39-1 (fumarate)

Description: F13714 is a Serotonin 5-HT1A Receptor Agonist. F13714 shows antidepressant-like properties after a single administration in the mouse model of chronic mild stress. F13714 has a high affinity (0.1 nM) and selectivity for 5-HT(1A) receptors. In vitro (18)F-F13714 binding in rats was consistent with the known 5-HT(1A) receptors distribution (hippocampus and cortical areas) and was particularly high in the dorsal raphe. In vitro binding of (18)F-F13714 was blocked in a dose-dependent fashion by WAY100635, the prototypical 5-HT(1A) antagonist, and by the endogenous agonist, serotonin (5-HT). Addition of Gpp(NH)p also inhibited in vitro (18)F-F13714 binding, consistent with a preferential binding of the compound to G-protein-coupled receptors. Ex vivo tissue measurements in rat revealed an absence of brain radioactive metabolites.


Chemical Structure

img
F13714 fumarate
CAS# 208109-39-1 (fumarate)

Theoretical Analysis

MedKoo Cat#: 556068
Name: F13714 fumarate
CAS#: 208109-39-1 (fumarate)
Chemical Formula: C25H29ClF2N4O5
Exact Mass:
Molecular Weight: 538.9768
Elemental Analysis: C, 55.71; H, 5.42; Cl, 6.58; F, 7.05; N, 10.40; O, 14.84

Price and Availability

Size Price Availability Quantity
25.0mg USD 550.0 2 Weeks
50.0mg USD 950.0 2 Weeks
100.0mg USD 1650.0 2 Weeks
200.0mg USD 2950.0 2 Weeks
500.0mg USD 3950.0 2 Weeks
Bulk inquiry

Related CAS #: 208109-39-1 (fumarate)   208109-38-0 (free base)    

Synonym: F13714 fumarate; F13714; F-13714; F 13714; F 14679; F-14679; F14679;

IUPAC/Chemical Name: 3-chloro-4-fluorophenyl-(4-fluoro-4-(((5-methyl-6-methylaminopyridin-2-ylmethyl)amino)methyl)piperidin-1-yl)methanone fumarate

InChi Key: HZJWIYFEDQNBEU-WLHGVMLRSA-N

InChi Code: InChI=1S/C21H25ClF2N4O.C4H4O4/c1-14-3-5-16(27-19(14)25-2)12-26-13-21(24)7-9-28(10-8-21)20(29)15-4-6-18(23)17(22)11-15;5-3(6)1-2-4(7)8/h3-6,11,26H,7-10,12-13H2,1-2H3,(H,25,27);1-2H,(H,5,6)(H,7,8)/b;2-1+

SMILES Code: O=C(C1=CC=C(F)C(Cl)=C1)N2CCC(CNCC3=NC(NC)=C(C)C=C3)(F)CC2.O=C(O)/C=C/C(O)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 538.9768 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: van Hagen BTJ, van Goethem NP, Nelissen E, Paes D, Koymans K, van Hoof S, Schreiber R, Varney M, Newman-Tancredi A, Prickaerts J. Biased 5-HT1A receptor agonists F13714 and NLX-101 differentially affect pattern separation and neuronal plasticity in rats after acute and chronic treatment. Mol Cell Neurosci. 2022 Mar 10;120:103719. doi: 10.1016/j.mcn.2022.103719. Epub ahead of print. PMID: 35283305.

2: Beecher K, Wang J, Chehrehasa F, Depoortere R, Varney MA, Newman-Tancredi A, Bartlett SE, Belmer A. Dissecting the contribution of 5-HT1A auto- and heteroreceptors in sucrose overconsumption in mice. Biomed Pharmacother. 2022 Apr;148:112699. doi: 10.1016/j.biopha.2022.112699. Epub 2022 Feb 11. PMID: 35152045.

3: Broadbear JH, Depoortere RY, Vacy K, Ralph D, Tunstall BJ, Newman-Tancredi A. Discriminative stimulus properties of the 5-HT1A receptor biased agonists NLX-101 and F13714, in rats trained to discriminate 8-OH-DPAT from saline. Behav Pharmacol. 2021 Dec 1;32(8):652-659. doi: 10.1097/FBP.0000000000000659. PMID: 34751175; PMCID: PMC8589115.

4: Głuch-Lutwin M, Sałaciak K, Gawalska A, Jamrozik M, Sniecikowska J, Newman- Tancredi A, Kołaczkowski M, Pytka K. The selective 5-HT1A receptor biased agonists, F15599 and F13714, show antidepressant-like properties after a single administration in the mouse model of unpredictable chronic mild stress. Psychopharmacology (Berl). 2021 Aug;238(8):2249-2260. doi: 10.1007/s00213-021-05849-0. Epub 2021 May 10. PMID: 33973045; PMCID: PMC8292235.

5: Depoortère R, Auclair AL, Newman-Tancredi A. NLX-101, a highly selective 5-HT1A receptor biased agonist, mediates antidepressant-like activity in rats via prefrontal cortex 5-HT1A receptors. Behav Brain Res. 2021 Mar 5;401:113082. doi: 10.1016/j.bbr.2020.113082. Epub 2020 Dec 25. PMID: 33358917.

6: Depoortere R, Bardin L, Auclair AL, Bruins Slot LA, Newman-Tancredi A. Marble Burying in NMRI Male Mice Is Preferentially Sensitive to Pre- Versus Postsynaptic 5-HT1A Receptor Biased Agonists. Pharmacology. 2021;106(1-2):114-118. doi: 10.1159/000509729. Epub 2020 Sep 18. PMID: 32950991.

7: Esquivel-Franco DC, de Boer SF, Waldinger M, Olivier B, Olivier JDA. Pharmacological Studies on the Role of 5-HT1A Receptors in Male Sexual Behavior of Wildtype and Serotonin Transporter Knockout Rats. Front Behav Neurosci. 2020 Mar 31;14:40. doi: 10.3389/fnbeh.2020.00040. PMID: 32296313; PMCID: PMC7136541.

8: Newman-Tancredi A, Cussac D, Ormière AM, Lestienne F, Varney MA, Martel JC. Bell-shaped agonist activation of 5-HT1A receptor-coupled Gαi3 G-proteins: Receptor density-dependent switch in receptor signaling. Cell Signal. 2019 Nov;63:109383. doi: 10.1016/j.cellsig.2019.109383. Epub 2019 Jul 31. PMID: 31376526.

9: Depoortère R, Bardin L, Varney MA, Newman-Tancredi A. Serotonin 5-HT1A Receptor Biased Agonists Display Differential Anxiolytic Activity in a Rat Social Interaction Model. ACS Chem Neurosci. 2019 Jul 17;10(7):3101-3107. doi: 10.1021/acschemneuro.8b00661. Epub 2019 Apr 2. PMID: 30929419.

10: Zhao Y, Bijlsma EY, Ter Heegde F, Verdouw MP, Garssen J, Newman-Tancredi A, Groenink L. Activation of somatodendritic 5-HT1A autoreceptors reduces the acquisition and expression of cued fear in the rat fear-potentiated startle test. Psychopharmacology (Berl). 2019 Apr;236(4):1171-1185. doi: 10.1007/s00213-018-5124-0. Epub 2018 Dec 12. PMID: 30539269; PMCID: PMC6591185.

11: Newman-Tancredi A, Varney MA, McCreary AC. Effects of the Serotonin 5-HT1A Receptor Biased Agonists, F13714 and F15599, on Striatal Neurotransmitter Levels Following L-DOPA Administration in Hemi-Parkinsonian Rats. Neurochem Res. 2018 May;43(5):1035-1046. doi: 10.1007/s11064-018-2514-y. Epub 2018 Mar 23. PMID: 29572645.

12: Brys I, Halje P, Scheffer-Teixeira R, Varney M, Newman-Tancredi A, Petersson P. Neurophysiological effects in cortico-basal ganglia-thalamic circuits of antidyskinetic treatment with 5-HT1A receptor biased agonists. Exp Neurol. 2018 Apr;302:155-168. doi: 10.1016/j.expneurol.2018.01.010. Epub 2018 Jan 13. PMID: 29339052.

13: Jastrzębska-Więsek M, Partyka A, Rychtyk J, Śniecikowska J, Kołaczkowski M, Wesołowska A, Varney MA, Newman-Tancredi A. Activity of Serotonin 5-HT1A Receptor Biased Agonists in Rat: Anxiolytic and Antidepressant-like properties. ACS Chem Neurosci. 2018 May 16;9(5):1040-1050. doi: 10.1021/acschemneuro.7b00443. Epub 2018 Jan 11. PMID: 29266914.

14: Meadows SM, Chambers NE, Conti MM, Bossert SC, Tasber C, Sheena E, Varney M, Newman-Tancredi A, Bishop C. Characterizing the differential roles of striatal 5-HT1A auto- and hetero-receptors in the reduction of l-DOPA-induced dyskinesia. Exp Neurol. 2017 Jun;292:168-178. doi: 10.1016/j.expneurol.2017.03.013. Epub 2017 Mar 23. PMID: 28342749.

15: Mombereau C, Arnt J, Mørk A. Involvement of presynaptic 5-HT1A receptors in the low propensity of brexpiprazole to induce extrapyramidal side effects in rats. Pharmacol Biochem Behav. 2017 Feb;153:141-146. doi: 10.1016/j.pbb.2016.12.015. Epub 2017 Jan 3. PMID: 28057524.

16: Yokoyama C, Mawatari A, Kawasaki A, Takeda C, Onoe K, Doi H, Newman-Tancredi A, Zimmer L, Onoe H. Marmoset Serotonin 5-HT1A Receptor Mapping with a Biased Agonist PET Probe 18F-F13714: Comparison with an Antagonist Tracer 18F-MPPF in Awake and Anesthetized States. Int J Neuropsychopharmacol. 2016 Dec 30;19(12):pyw079. doi: 10.1093/ijnp/pyw079. PMID: 27608810; PMCID: PMC5203761.

17: Becker G, Bolbos R, Costes N, Redouté J, Newman-Tancredi A, Zimmer L. Selective serotonin 5-HT1A receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study. Sci Rep. 2016 May 23;6:26633. doi: 10.1038/srep26633. PMID: 27211078; PMCID: PMC4876409.

18: de Boer SF, Newman-Tancredi A. Anti-aggressive effects of the selective high-efficacy 'biased' 5-HT₁A receptor agonists F15599 and F13714 in male WTG rats. Psychopharmacology (Berl). 2016 Mar;233(6):937-47. doi: 10.1007/s00213-015-4173-x. Epub 2015 Dec 23. PMID: 26694810; PMCID: PMC4759229.

19: Iderberg H, McCreary AC, Varney MA, Cenci MA, Newman-Tancredi A. Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia. Neuropharmacology. 2015 Jun;93:52-67. doi: 10.1016/j.neuropharm.2015.01.012. Epub 2015 Jan 31. PMID: 25645393.

20: van Goethem NP, Schreiber R, Newman-Tancredi A, Varney M, Prickaerts J. Divergent effects of the 'biased' 5-HT1 A receptor agonists F15599 and F13714 in a novel object pattern separation task. Br J Pharmacol. 2015 May;172(10):2532-43. doi: 10.1111/bph.13071. Epub 2015 Feb 27. PMID: 25572672; PMCID: PMC4409905.